Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent completion of a new non-GMP drug development facility at ...
read more
Monday, November 17, 2014
Almac Group today announced that it has launched a CLIA validated next generation sequencing test for P53 mutations. The P53 test can be run on formalin fixed paraffin embedded (FFPE) samples enabling patient stratification for early phase trial ...
read more
Almac has received a renewal of its GMP/GDP certification following the successful regulatory inspection by the Health Sciences Authority (HSA) of its facility in Singapore.
read more
Tuesday, February 28, 2012
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, has addressed a surge in clinical outsourcing by acquiring two new pieces of encapsulation equipment at their North American headquarters in Souderton...
read more
Almac Clinical Technologies has announced the expedited deployment and support of multiple IRT solutions in support of COVID-19 treatments.
read more
Almac Discovery, the research driven drug discovery company and a member of the Almac Group announced a new research collaboration with HitGen Inc., a provider of DNA-encoded library (DEL) technology for novel chemical equity (NCE) generation.
read more
Dedicated temperature and humidity controlled labelling suites go live in USA and Europe as business from biosimilars and biologics clinical studies expands
read more
Wednesday, August 30, 2023
Almac Diagnostic Services, a member of the Almac Group, has announced investment to expand its Next Generation Sequencing (NGS) capabilities for BioPharma partners, following the purchase and installation of the first Illumina NovaSeq™ X Plus ...
read more
Thursday, October 24, 2013
With the opening of a new commercial packaging facility in the US and enhanced processing capabilities at the company’s Headquarters in Craigavon, UK, investments in the past year has substantially transformed the commercial business unit of Almac.
read more
Friday, November 11, 2016
Almac Group, the global contract pharmaceutical development and manufacturing organization has announced plans to expand its operations in Europe and North America increasing its global headcount to reach 5,000 by 2017.
read more
Tuesday, January 07, 2014
Almac Group Limited (“Almac”) and Key Organics Limited (“Key Organics”) today announced that they have entered into an exclusive supply & marketing agreement.
read more
Almac Group announces Almac One™ - providing the first unified Clinical Trial Supply solution.
read more
The Almac Group announced the appointment of Graeme McBurney to the Board of Directors in the role of Chief Operating Officer effective 1st October 2022.
read more
Almac Sciences announced the appointment of Dr. Sheryl Foster to the position of Vice President of Quality, reporting to Managing Director & President, Dr. Stephen Barr.
read more
Almac Group has announced the appointment of three new Vice Presidents within its Pharma Services Business Unit as it expands its executive team.
read more